Search

Your search keyword '"Mark, Patrick B"' showing total 1,081 results

Search Constraints

Start Over You searched for: Author "Mark, Patrick B" Remove constraint Author: "Mark, Patrick B"
1,081 results on '"Mark, Patrick B"'

Search Results

3. Socioeconomic deprivation and illness trajectory in the Scottish population after COVID-19 hospitalization

5. Differential Associations of Cystatin C Versus Creatinine-Based Kidney Function With Risks of Cardiovascular Event and Mortality Among South Asian Individuals in the UK Biobank.

11. Contributors

13. Description and Cross-Sectional Analyses of 25,880 Adults and Children in the UK National Registry of Rare Kidney Diseases Cohort

17. Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort

18. The NightLife study — the clinical and cost-effectiveness of thrice-weekly, extended, in-centre nocturnal haemodialysis versus daytime haemodialysis using a mixed methods approach: study protocol for a randomised controlled trial

19. Stopping Versus Continuing Metformin in Patients With Advanced CKD: A Nationwide Scottish Target Trial Emulation Study

20. Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD

27. An Analysis of Vascular Access Thrombosis Events From the Proactive IV irOn Therapy in hemodiALysis Patients Trial

28. A multisystem, cardio-renal investigation of post-COVID-19 illness

29. Sex differences in cancer outcomes across the range of eGFR.

31. Management of Hypertension in Patients With Diabetic Kidney Disease: Summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2021

33. Grams ME, Sang Y, Ballew SH, et al, for the Chronic Kidney Disease Prognosis Consortium. Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int. 2018;93:1442–1451

34. Evans M, Grams ME, Sang Y, et al., for the Chronic Kidney Disease Prognosis Consortium. Risk factors for prognosis in patients with severely decreased GFR. Kidney Int Rep. 2018;3:625–637

37. Measuring congestion with a non‐invasive monitoring device in heart failure and haemodialysis: CONGEST‐HF

38. Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS‐MI): rationale and design

39. Description and cross-sectional analyses of 25,880 adults and children in the UK National Registry of Rare Kidney Diseases cohort

43. Three week compared to seven week run-in period length and the assessment of pre-randomization adherence: A study within a trial

45. Genetic epidemiology of SARS-CoV-2 transmission in renal dialysis units – A high risk community-hospital interface

46. Central and peripheral arterial diseases in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

47. Effects of Dapagliflozin in Patients with Membranous Nephropathy

Catalog

Books, media, physical & digital resources